Universal Health Realty Income Trust filed its Form 10-Q for the quarterly period ended September 30, 2026, reporting net income of $4.929 million for the third quarter and $15.855 million for the nine months ended September 30, 2026.

Key Highlights

  • Q3 2026 net income: $4.929 million, compared to $4.016 million in Q3 2025, according to the filing.
  • Nine-month net income: $15.855 million for the nine months ended September 30, 2026, up from $13.285 million in the same period of 2025.
  • Q3 diluted earnings per share: $0.35, versus $0.29 in Q3 2025, as reported in the condensed consolidated statements of income.
  • Total revenues: $25.346 million for Q3 2026 and $74.866 million for the nine months ended September 30, 2026.
  • Total assets: $573.013 million as of September 30, 2026, compared to $564.907 million at December 31, 2025.
  • Line of credit borrowings: $377.700 million as of September 30, 2026, up from $356.200 million at December 31, 2025.
  • Shares outstanding: 13,899,682 common shares as of the balance sheet date, with 13,899,689 outstanding as of October 31, 2026.

Universal Health Realty Income Trust Third Quarter 2026 Financial Results

Universal Health Realty Income Trust (NYSE:UHT), a Maryland real estate investment trust, disclosed its unaudited condensed consolidated financial results for Q3 2026 in a Form 10-Q filed November 6, 2026. According to the filing, total revenues for the three months ended September 30, 2026 were $25.346 million, compared to $25.302 million in Q3 2025. For the nine-month period, revenues totaled $74.866 million versus $74.718 million in the prior-year period. Lease revenue from UHS facilities contributed $8.421 million in Q3 2026, and lease revenue from non-related parties contributed $14.897 million.

The filing reported that Q3 2026 net income was $4.929 million, or $0.35 per diluted share, compared to $4.016 million, or $0.29 per diluted share, in Q3 2025. For the nine months ended September 30, 2026, net income was $15.855 million, or $1.14 per diluted share, versus $13.285 million, or $0.96 per diluted share, in the same period of 2025. The filing also noted a gain on sale of land of $724 thousand recorded in the nine-month period, with no comparable amount in 2025. Total interest expense, net, was $4.529 million for Q3 2026, compared to $4.816 million in Q3 2025.

On the balance sheet, the Trust reported net real estate investments of $417.330 million as of September 30, 2026, compared to $410.010 million at December 31, 2025. Total liabilities rose to $433.512 million from $412.523 million at year-end 2025, driven in part by an increase in line of credit borrowings. The filing also disclosed that as of September 30, 2026, the Trust held investments in four jointly-owned LLCs/LPs, with equity in income of unconsolidated LLCs of $497 thousand in Q3 2026. The Advisory Agreement with UHS of Delaware, Inc., a wholly-owned subsidiary of Universal Health Services, Inc., was renewed for 2026 on the same terms as 2025 and 2024, according to the filing.

What Was Disclosed

The filing covers unaudited financial results for the three and nine months ended September 30, 2026, including income statements, balance sheets, and cash flow data, along with details on related-party arrangements with Universal Health Services, Inc. and equity investments in unconsolidated LLCs.